| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,553 | 8,385 | 12,012 | 10,426 | | Cost of Revenue | 9,521 | 9,973 | 13,941 | 11,765 | | | Gross Profit | (1,969) | (1,588) | (1,929) | (1,339) | | | Operating Expenses | | Research Development | 15 | 28 | 18 | 14 | | Selling General and Administrative | 739 | 1,015 | 848 | 901 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,723) | (2,631) | (2,795) | (2,254) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6 | (4) | (118) | 493 | | Earnings Before Interest And Taxes | (3,604) | (2,635) | (2,913) | (1,761) | | Interest Expense | (462) | 462 | 198 | 480 | | Income Before Tax | (3,142) | (3,097) | (3,110) | (2,241) | | Income Tax Expense | 31 | 55 | (1,240) | (137) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,173) | (3,152) | (1,871) | (2,104) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,173) | (3,152) | (1,871) | (2,104) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,173) | ($3,152) | ($1,871) | ($2,104) |
|
0.29% Nasdaq 
Income Statement
